As the COVID-19 pandemic enters a new phase, punctuated by emerging hot spots and continuing global spread, a new analytical tool developed by RAND Corporation researchers allows policymakers to predict regional risks of importing cases of COVID-19. The tool, which melds information on infection rates with global air traffic data, has already produced a number…
Scientists at the University of Liverpool and University of Utrecht have taken another step forward on their quest to develop a viable drug based on teixobactin – a new class of potent natural antibiotic capable of killing superbugs. Research published in Nature Communications provides fundamental new insights into how teixobactins kill bacteria, including the discovery…
Sofya Kulikova, a researcher at HSE University in Perm, is part of an international research team that has discovered potential mechanisms that explain the sleep spindle deficit in electroencephalograms (EEG) of people with schizophrenia. The article was published in the Schizophrenia Research on June 5. https://www.sciencedirect.com/science/article/abs/pii/S092099642030236X?via%3Dihub&fbclid=IwAR2VFGlKtqeYMsdtFidYS5yNpbarRGRA8Wts6TkIOCiWyDfkBot7z_yJs7w Individuals with schizophrenia are often characterized by a deficit…
Germany was not hit as hard by the SARS-CoV-2 pandemic as many other European countries. The reason for this is that the wave of infection reached Germany later, that the authorities were warned by the situation in Italy and Spain and at an early stage ordered a lockdown and conducted extensive testing. Up to June…
The increase in antibiotic resistance and the lack of new antibiotics is currently a major global health problem. Reducing the use of antibiotics appears to be one of the only solutions to preserve their effectiveness and limit the emergence of resistance. Relatively long courses of treatment remain standard, however, although they seem to be based…
The Society for Risk Analysis (SRA), the world’s leading authority on risk sciences and its applications, is hosting a webinar on Thursday, June 11 at 11 a.m. ET to discuss the latest research on aerosol transmission of COVID-19. The discussion will be hosted by Seth Guikema, Ph.D., president of the Society, and will feature…
Narayanan Studying Application Of Brilacidin For Treatment Of Coronavirus Infections Aarthi Narayanan, Assistant Professor, National Center for Biodefense and Infectious Diseases, received $35,000 from Innovation Pharmaceuticals, Inc., for a project in which she is examining the use of Brilacidin for the treatment of coronavirus infections. Brilacidin is an investigational new drug. It is a polymer-based…
Frontiers in Clinical Drug Research – Dementia is a book series which presents comprehensive reviews about research on Dementia, a term which references the loss of brain function associated with Alzheimer’s disease and other related medical conditions. The disease affects the parts of the brain that deal with memory, thought, and language. Chapters in each…
Newly compiled prescription data shows that President Trump’s decision to take an antimalarial drug to ward off the coronavirus did not inspire many Americans to do the same, reflecting the fast-changing landscape surrounding the virus and efforts to treat it. First-time prescriptions ticked up by only several hundred the day after Mr. Trump mentioned at…
WASHINGTON — The Trump administration on Thursday released new requirements for states to report coronavirus data based on race, ethnicity, age and sex of individuals tested for the virus, responding to demands from lawmakers for a clearer picture of the pandemic and its racial discrepancies. All laboratories — as well as nonlaboratory facilities offering on-site…